Showing results (91-100 of 252) with videos related to
Sort By:
Pageof 26
British Journal of Haematology|June 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromesVirginia O Volpe, Najla Al Ali, Onyee Chan, et al.Clinical Lymphoma, Myeloma & Leukemia|February 12, 2020
Decoding Bone Marrow Fibrosis in Myelodysplastic SyndromesMegan Melody, Najla Al Ali, Ling Zhang, et al.Leukemia Research|February 8, 2025
Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML)Zena Komrokji, Najla Al Ali, Zhuoer Xie, et al.Frontiers in Cardiovascular Medicine|May 8, 2026
miR-181a post-transcriptionally targets GRK2 to limit maladaptive signaling in cardiomyocytesHeidi Cho, Melissa Lieu, Erhe Gao, et al.Leukemia & Lymphoma|June 11, 2021
What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?Rami Komrokji, Najla Al Ali, Eric Padron, et al.Journal of Virology|March 30, 2005
Structure of adeno-associated virus type 4Eric Padron, Valorie Bowman, Nikola Kaludov, et al.Clinical Lymphoma, Myeloma & Leukemia|June 27, 2022
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid LeukemiaDasom Lee, Akriti G Jain, Yehuda Deutsch, et al.Clinical Lymphoma, Myeloma & Leukemia|March 7, 2020
Defining Acute Myeloid Leukemia Ontogeny in Older PatientsMegan Melody, Andrew Kuykendall, David Sallman, et al.Journal of Virology|August 31, 2007
Structure of adeno-associated virus serotype 8, a gene therapy vectorHyun-Joo Nam, Michael Douglas Lane, Eric Padron, et al.Clinical Lymphoma, Myeloma & Leukemia|April 20, 2025
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease ProgressionLuis E Aguirre, Somedeb Ball, Akriti Jain, et al.Pageof 26